Sharing anonymized MRI data for small bowel diseases

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to share anonymized MRI datasets and relevant clinical data related to small bowel diseases, particularly Crohn's disease, to enhance understanding and management of these conditions. The study will collect data from patients who underwent small bowel MRI at University College London Hospital between 2005 and 2010, ensuring that these datasets are linked to clinical standards of reference. By collaborating with partners like the Centre for Medical Image Computing and a European consortium, the study seeks to validate MRI findings against established clinical benchmarks. The goal is to improve the accuracy and efficiency of MRI assessments in clinical practice.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Had a small bowel MRI at UCLH between 2005 and Sept 2010 as part of routine clinical practice who:
* Have a clinical standard of reference within 6 weeks of the MRI scan
* Patients with normal small bowel MRI studies and no clinical evidence of bowel pathology on any additional diagnostic investigations

Exclusion Criteria:

* Patients \<16 or not fulfilling either inclusion criteria

Where it's running

• University College London Hospital
  London, United Kingdom Recruiting

Study contacts

• Principal investigator: Stuart Taylor — University College, London
• Study coordinator: Neela Ramchurn
• Email: n.ramchurn1@nhs.net

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Histology and molecular profiling of small-bowel biopsies to improve celiac care

  This project will test whether digital imaging, AI, gene-level profiling, and lab-grown intestinal cells can help diagnose and understand celiac disease and related small-bowel problems in adults having a gastroscopy.

  Recruiting at 3 sites Tampere University Hospital · Tampere and 2 other locations · NCT07556328

• Microbiome in esophageal and stomach leaks

  This project will test whether microbes in leaked fluid and nearby tissue from adults with esophageal or stomach leaks differ in ways that affect healing and complications.

  Recruiting Baylor Research Institute · Dallas, Texas · NCT07424469

• Signia circular stapler for left-sided colon, sigmoid, and rectal resections

  This study will try the Signia circular stapler with Tri-Staple technology to see if it safely creates bowel reconnections in adults having left-sided colon, sigmoid, or rectal surgery.

  Recruiting at 6 sites Medtronic - MITG · New Haven, Connecticut and 9 other locations · NCT07351071

• PF-08634404 plus chemotherapy for adults with metastatic colorectal cancer

  This trial will test whether adding a new drug called PF-08634404 to standard chemotherapy helps adults whose colorectal cancer has spread.

  Recruiting at 343 sites Phase 3 Pfizer · Chandler, Arizona and 371 other locations · NCT07222800

• Validation of a new platform for monitoring pH in abdominal drainage fluid

  This study is testing a new device that checks the acidity of fluid from the abdomen after surgery to see if it can help spot problems early in patients.

  Recruiting FluidAI Medical · Hamilton, Ontario · NCT06541431

• Fecal microbiota transplantation for autism spectrum disorder

  This study is testing whether a treatment that involves transplanting healthy gut bacteria can help improve gut and autism symptoms in young people with autism spectrum disorder.

  Recruiting Phase 1/2 Chang Gung Memorial Hospital · Taoyuan City · NCT06290258

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.